Skip to content
Hallucinogen-Related ED Visits Associated With Schizophrenia Risk
11/14/24 12:00 AM
Lykos Therapeutics’ Psychedelic MDMA Not Approved by FDA
8/12/24 12:00 AM
FDA Expert Panel Votes Against Approval of Psychedelic Drug MDMA for PTSD
6/5/24 12:00 AM
Calls to Poison Centers Involving Psilocybin on the Rise Among Young People
2/26/24 12:00 AM
This is a search field with an auto-suggest feature attached.
There are no suggestions because the search field is empty.
Follow us on X
Follow us on Instagram
Follow us on LinkedIn
Follow us on YouTube
Subscribe Here!
News From Current Issue
Special Report: Communicating the Neurobiology of MDD
Why Narcolepsy Is Often Missed—and How to Spot It
Integrating Psychiatric Pharmacists Into Practice
Read This Week's Update
